Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3845848

Fc1ccccc1-c1n[nH]cc1-c1ccc2ncc(-c3ccc4c(c3)OCO4)n2c1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FYN P06241 17/20 0.42
DYRK1A Q13627 1/20 0.40
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MET P08581 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3850035 0.92 FYN (0.43) FYNDYRK1AKDM4EALDH1A1TP53
Trifluoroacetic Acid SCHEMBL3851547 0.88 TGFBR1 (0.39)
Trifluoroacetic Acid SCHEMBL3849822 0.87 TGFBR1 (0.37) DYRK1A
Trifluoroacetic Acid SCHEMBL3852898 0.79 TGFBR1 (0.38) DYRK1A
Trifluoroacetic Acid SCHEMBL3852891 0.79 TGFBR1 (0.38)
SCHEMBL13874552 0.78 CLK1 (0.41) DYRK1A
Trifluoroacetic Acid SCHEMBL5851891 0.78 TGFBR1 (0.36) KDM4EALDH1A1TP53HPGDHSD17B10
Trifluoroacetic Acid SCHEMBL3854224 0.77 TGFBR1 (0.36) ALDH1A1TP53
SCHEMBL13874245 0.77 FLT3 (0.48) DYRK1A
Hydrochloric Acid SCHEMBL4714547 0.76 FLT3 (0.47) DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed